Caris Life Sciences expects full year 2026 revenue to be in the range of $1.0 billion to $1.02 billion, representing growth ...
Q4 2025 Earnings Call February 26, 2026 4:30 PM ESTCompany ParticipantsMike Brophy - Chief Financial OfficerSteve Chapman - CEO ...
Castle Biosciences, Inc. ( CSTL) Q4 2025 Earnings Call February 26, 2026 4:30 PM EST Good afternoon, and welcome to Castle Biosciences Fourth Quarter and Full Year 2025 Conference Call. As a reminder, ...
In the strong fourth quarter, Aixtron achieved an EBIT of €58.0m (EBIT margin of 31 percent), matching the very strong margin from the prior-year quarter, although the absolute result was lower ...
A high-level delegation of 23 French companies travelled to India last week as part of the official launch of the India-France Year of Innovation 2026, inaugurated jointly in Mumbai by French ...
Leg-spinner Yuzvendra Chahal's maiden six-wicket for India as the hosts beat England by 75 runs in the third and final Twenty20 International ...
Castle Biosciences (NASDAQ:CSTL) reported fourth-quarter revenue of $87.0 million and full-year 2025 revenue of $344.2 ...
Moby summary of Tempus AI, Inc.'s Q4 2025 earnings call ...
Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy" the "Company" or "we"), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today announced its unaudited financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results